Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

PROF vs EDAP vs ISRG vs AEYE vs MDT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PROF
Profound Medical Corp.

Medical - Devices

HealthcareNASDAQ • CA
Market Cap$217M
5Y Perf.-44.5%
EDAP
Edap Tms S.a.

Medical - Devices

HealthcareNASDAQ • FR
Market Cap$156M
5Y Perf.+53.0%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+132.8%
AEYE
AudioEye, Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$100M
5Y Perf.-7.2%
MDT
Medtronic plc

Medical - Devices

HealthcareNYSE • IE
Market Cap$99.94B
5Y Perf.-22.8%

PROF vs EDAP vs ISRG vs AEYE vs MDT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PROF logoPROF
EDAP logoEDAP
ISRG logoISRG
AEYE logoAEYE
MDT logoMDT
IndustryMedical - DevicesMedical - DevicesMedical - Instruments & SuppliesSoftware - ApplicationMedical - Devices
Market Cap$217M$156M$161.07B$100M$99.94B
Revenue (TTM)$14M$70M$10.58B$40M$35.48B
Net Income (TTM)$-25M$-13M$2.98B$-3M$4.61B
Gross Margin69.1%46.8%66.3%78.3%61.9%
Operating Margin-287.4%-38.2%30.5%-7.9%17.9%
Forward P/E5.1x43.3x14.1x
Total Debt$6M$28M$303M$721K$28.52B
Cash & Equiv.$82M$17M$3.37B$5M$2.22B

PROF vs EDAP vs ISRG vs AEYE vs MDTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PROF
EDAP
ISRG
AEYE
MDT
StockMay 20May 26Return
Profound Medical Co… (PROF)10055.5-44.5%
Edap Tms S.a. (EDAP)100153.0+53.0%
Intuitive Surgical,… (ISRG)100232.8+132.8%
AudioEye, Inc. (AEYE)10092.8-7.2%
Medtronic plc (MDT)10077.2-22.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: PROF vs EDAP vs ISRG vs AEYE vs MDT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MDT leads in 3 of 7 categories (5-stock set), making it the strongest pick for capital preservation and lower volatility and dividend income and shareholder returns. Profound Medical Corp. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. EDAP and ISRG also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
PROF
Profound Medical Corp.
The Growth Play

PROF is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 61.1%, EPS growth 231.8%, 3Y rev CAGR 34.8%
  • 61.1% revenue growth vs MDT's 3.6%
  • Better valuation composite
Best for: growth exposure
EDAP
Edap Tms S.a.
The Momentum Pick

EDAP ranks third and is worth considering specifically for momentum.

  • +80.9% vs AEYE's -27.9%
Best for: momentum
ISRG
Intuitive Surgical, Inc.
The Long-Run Compounder

ISRG is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 5.5% 10Y total return vs MDT's 26.5%
  • Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
  • PEG 1.99 vs MDT's 36.00
  • 28.2% margin vs PROF's -184.2%
Best for: long-term compounding and sleep-well-at-night
AEYE
AudioEye, Inc.
The Technology Pick

Among these 5 stocks, AEYE doesn't own a clear edge in any measured category.

Best for: technology exposure
MDT
Medtronic plc
The Income Pick

MDT carries the broadest edge in this set and is the clearest fit for income & stability and defensive.

  • Dividend streak 36 yrs, beta 0.47, yield 3.6%
  • Beta 0.47, yield 3.6%, current ratio 1.85x
  • Beta 0.47 vs AEYE's 2.29
  • 3.6% yield; 36-year raise streak; the other 4 pay no meaningful dividend
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthPROF logoPROF61.1% revenue growth vs MDT's 3.6%
ValuePROF logoPROFBetter valuation composite
Quality / MarginsISRG logoISRG28.2% margin vs PROF's -184.2%
Stability / SafetyMDT logoMDTBeta 0.47 vs AEYE's 2.29
DividendsMDT logoMDT3.6% yield; 36-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)EDAP logoEDAP+80.9% vs AEYE's -27.9%
Efficiency (ROA)MDT logoMDT175.8% ROA vs PROF's -27.8%, ROIC 6.0% vs -239.6%

PROF vs EDAP vs ISRG vs AEYE vs MDT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PROFProfound Medical Corp.
FY 2025
Recurring - Non-Capital
60.4%$10M
Capital Equipment
39.6%$6M
EDAPEdap Tms S.a.
FY 2025
Goods
69.3%$49M
Spare parts and services
16.1%$11M
RPP's and leases
14.6%$10M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
AEYEAudioEye, Inc.
FY 2024
Enterprise
100.0%$15M
MDTMedtronic plc
FY 2025
Cardiac and Vascular Group
37.3%$12.5B
Neuroscience Group
29.4%$9.8B
Medical Surgical
25.1%$8.4B
Diabetes Group
8.2%$2.8B

PROF vs EDAP vs ISRG vs AEYE vs MDT — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGAEYE

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 3 of 6 comparable metrics.

MDT is the larger business by revenue, generating $35.5B annually — 2626.5x PROF's $14M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to PROF's -184.2%. On growth, EDAP holds the edge at +31.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPROF logoPROFProfound Medical …EDAP logoEDAPEdap Tms S.a.ISRG logoISRGIntuitive Surgica…AEYE logoAEYEAudioEye, Inc.MDT logoMDTMedtronic plc
RevenueTrailing 12 months$14M$70M$10.6B$40M$35.5B
EBITDAEarnings before interest/tax-$38M-$24M$3.8B-$504,000$9.4B
Net IncomeAfter-tax profit-$25M-$13M$3.0B-$3M$4.6B
Free Cash FlowCash after capex-$39M-$17M$2.8B$2M$5.4B
Gross MarginGross profit ÷ Revenue+69.1%+46.8%+66.3%+78.3%+61.9%
Operating MarginEBIT ÷ Revenue-2.9%-38.2%+30.5%-7.9%+17.9%
Net MarginNet income ÷ Revenue-184.2%-18.9%+28.2%-7.6%+13.0%
FCF MarginFCF ÷ Revenue-2.9%-25.1%+26.8%+5.5%+15.2%
Rev. Growth (YoY)Latest quarter vs prior year-100.0%+31.4%+23.0%+7.9%+8.8%
EPS Growth (YoY)Latest quarter vs prior year+152.8%+2.3%+18.8%+29.0%-11.9%
ISRG leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

MDT leads this category, winning 4 of 7 comparable metrics.

At 5.1x trailing earnings, PROF trades at a 91% valuation discount to ISRG's 57.6x P/E. Adjusting for growth (PEG ratio), ISRG offers better value at 2.65x vs MDT's 36.00x — a lower PEG means you pay less per unit of expected earnings growth.

MetricPROF logoPROFProfound Medical …EDAP logoEDAPEdap Tms S.a.ISRG logoISRGIntuitive Surgica…AEYE logoAEYEAudioEye, Inc.MDT logoMDTMedtronic plc
Market CapShares × price$217M$156M$161.1B$100M$99.9B
Enterprise ValueMkt cap + debt − cash$141M$166M$158.0B$96M$126.2B
Trailing P/EPrice ÷ TTM EPS5.08x-5.33x57.62x-32.36x21.60x
Forward P/EPrice ÷ next-FY EPS est.43.35x14.13x
PEG RatioP/E ÷ EPS growth rate2.65x36.00x
EV / EBITDAEnterprise value multiple43.62x14.32x
Price / SalesMarket cap ÷ Revenue13.23x2.20x16.00x2.49x2.98x
Price / BookPrice ÷ Book value/share2.38x8.02x9.17x20.91x2.08x
Price / FCFMarket cap ÷ FCF64.67x19.28x
MDT leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 6 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-65 for EDAP. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to EDAP's 1.43x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs EDAP's 3/9, reflecting solid financial health.

MetricPROF logoPROFProfound Medical …EDAP logoEDAPEdap Tms S.a.ISRG logoISRGIntuitive Surgica…AEYE logoAEYEAudioEye, Inc.MDT logoMDTMedtronic plc
ROE (TTM)Return on equity-44.9%-65.4%+16.9%-47.8%+9.4%
ROA (TTM)Return on assets-27.8%-18.8%+14.8%-9.5%+175.8%
ROICReturn on invested capital-2.4%-69.2%+15.0%-42.4%+6.0%
ROCEReturn on capital employed-33.8%-56.0%+16.5%-17.7%+7.5%
Piotroski ScoreFundamental quality 0–953646
Debt / EquityFinancial leverage0.07x1.43x0.02x0.15x0.59x
Net DebtTotal debt minus cash-$75M$10M-$3.1B-$5M$26.3B
Cash & Equiv.Liquid assets$82M$17M$3.4B$5M$2.2B
Total DebtShort + long-term debt$6M$28M$303M$721,000$28.5B
Interest CoverageEBIT ÷ Interest expense-16.21x-2.79x9.08x
ISRG leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $3,546 for PROF. Over the past 12 months, EDAP leads with a +80.9% total return vs AEYE's -27.9%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs EDAP's -28.4% — a key indicator of consistent wealth creation.

MetricPROF logoPROFProfound Medical …EDAP logoEDAPEdap Tms S.a.ISRG logoISRGIntuitive Surgica…AEYE logoAEYEAudioEye, Inc.MDT logoMDTMedtronic plc
YTD ReturnYear-to-date-6.5%+22.4%-19.3%-18.7%-18.1%
1-Year ReturnPast 12 months+48.9%+80.9%-15.4%-27.9%-2.8%
3-Year ReturnCumulative with dividends-47.9%-63.3%+49.6%+20.6%-4.2%
5-Year ReturnCumulative with dividends-64.5%-37.8%+58.7%-60.2%-27.7%
10-Year ReturnCumulative with dividends-26.3%+18.9%+554.2%+102.2%+26.5%
CAGR (3Y)Annualised 3-year return-19.5%-28.4%+14.4%+6.4%-1.4%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — EDAP and MDT each lead in 1 of 2 comparable metrics.

MDT is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than AEYE's 2.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EDAP currently trades 82.4% from its 52-week high vs AEYE's 49.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPROF logoPROFProfound Medical …EDAP logoEDAPEdap Tms S.a.ISRG logoISRGIntuitive Surgica…AEYE logoAEYEAudioEye, Inc.MDT logoMDTMedtronic plc
Beta (5Y)Sensitivity to S&P 5001.52x0.74x1.00x2.18x0.42x
52-Week HighHighest price in past year$8.95$5.05$603.88$16.39$106.33
52-Week LowLowest price in past year$3.76$1.21$427.84$5.31$77.16
% of 52W HighCurrent price vs 52-week peak+80.0%+82.4%+75.1%+49.4%+73.3%
RSI (14)Momentum oscillator 0–10060.154.842.461.327.3
Avg Volume (50D)Average daily shares traded212K38K1.8M194K7.8M
Evenly matched — EDAP and MDT each lead in 1 of 2 comparable metrics.

Analyst Outlook

MDT leads this category, winning 1 of 1 comparable metric.

Analyst consensus: PROF as "Buy", EDAP as "Buy", ISRG as "Buy", MDT as "Buy". Consensus price targets imply 67.6% upside for PROF (target: $12) vs 37.3% for ISRG (target: $623). MDT is the only dividend payer here at 3.57% yield — a key consideration for income-focused portfolios.

MetricPROF logoPROFProfound Medical …EDAP logoEDAPEdap Tms S.a.ISRG logoISRGIntuitive Surgica…AEYE logoAEYEAudioEye, Inc.MDT logoMDTMedtronic plc
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$12.00$6.00$622.60$109.50
# AnalystsCovering analysts785549
Dividend YieldAnnual dividend ÷ price+3.6%
Dividend StreakConsecutive years of raises136
Dividend / ShareAnnual DPS$2.78
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+1.4%0.0%+3.2%
MDT leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MDT leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 3 of 6 categories
Loading custom metrics...

PROF vs EDAP vs ISRG vs AEYE vs MDT: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is PROF or EDAP or ISRG or AEYE or MDT a better buy right now?

For growth investors, Profound Medical Corp.

(PROF) is the stronger pick with 61. 1% revenue growth year-over-year, versus 3. 6% for Medtronic plc (MDT). Profound Medical Corp. (PROF) offers the better valuation at 5. 1x trailing P/E, making it the more compelling value choice. Analysts rate Profound Medical Corp. (PROF) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PROF or EDAP or ISRG or AEYE or MDT?

On trailing P/E, Profound Medical Corp.

(PROF) is the cheapest at 5. 1x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, Medtronic plc is actually cheaper at 14. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Intuitive Surgical, Inc. wins at 1. 99x versus Medtronic plc's 36. 00x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — PROF or EDAP or ISRG or AEYE or MDT?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +58. 7%, compared to -64. 5% for Profound Medical Corp. (PROF). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus PROF's -29. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PROF or EDAP or ISRG or AEYE or MDT?

By beta (market sensitivity over 5 years), Medtronic plc (MDT) is the lower-risk stock at 0.

42β versus AudioEye, Inc. 's 2. 18β — meaning AEYE is approximately 414% more volatile than MDT relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 143% for Edap Tms S. a. — giving it more financial flexibility in a downturn.

05

Which is growing faster — PROF or EDAP or ISRG or AEYE or MDT?

By revenue growth (latest reported year), Profound Medical Corp.

(PROF) is pulling ahead at 61. 1% versus 3. 6% for Medtronic plc (MDT). On earnings-per-share growth, the picture is similar: Profound Medical Corp. grew EPS 231. 8% year-over-year, compared to -52. 9% for Edap Tms S. a.. Over a 3-year CAGR, PROF leads at 34. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PROF or EDAP or ISRG or AEYE or MDT?

Profound Medical Corp.

(PROF) is the more profitable company, earning 258. 4% net margin versus -41. 5% for Edap Tms S. a. — meaning it keeps 258. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -256. 3% for PROF. At the gross margin level — before operating expenses — AEYE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PROF or EDAP or ISRG or AEYE or MDT more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Intuitive Surgical, Inc. (ISRG) is the more undervalued stock at a PEG of 1. 99x versus Medtronic plc's 36. 00x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Medtronic plc (MDT) trades at 14. 1x forward P/E versus 43. 3x for Intuitive Surgical, Inc. — 29. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PROF: 67. 6% to $12. 00.

08

Which pays a better dividend — PROF or EDAP or ISRG or AEYE or MDT?

In this comparison, MDT (3.

6% yield) pays a dividend. PROF, EDAP, ISRG, AEYE do not pay a meaningful dividend and should not be held primarily for income.

09

Is PROF or EDAP or ISRG or AEYE or MDT better for a retirement portfolio?

For long-horizon retirement investors, Medtronic plc (MDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

42), 3. 6% yield). AudioEye, Inc. (AEYE) carries a higher beta of 2. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MDT: +24. 3%, AEYE: +96. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PROF and EDAP and ISRG and AEYE and MDT?

These companies operate in different sectors (PROF (Healthcare) and EDAP (Healthcare) and ISRG (Healthcare) and AEYE (Technology) and MDT (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PROF is a small-cap high-growth stock; EDAP is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock; AEYE is a small-cap quality compounder stock; MDT is a mid-cap income-oriented stock. MDT pays a dividend while PROF, EDAP, ISRG, AEYE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

PROF

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 41%
Run This Screen
Stocks Like

EDAP

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 15%
  • Gross Margin > 28%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

AEYE

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 46%
Run This Screen
Stocks Like

MDT

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PROF and EDAP and ISRG and AEYE and MDT on the metrics below

Revenue Growth>
%
(PROF: -100.0% · EDAP: 31.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.